| Serial Number | 79247187 |
| Word Mark | RYLANAX |
| Filing Date | Wednesday, September 26, 2018 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Thursday, February 10, 2022 |
| Registration Number | 5760081 |
| Registration Date | Tuesday, May 28, 2019 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 12, 2019 |
| Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma |
| Transliteration Statement | The wording "RYLANAX" has no meaning in a foreign language. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | H - NOT AVAILABLE |
| Class Status Date | Thursday, February 10, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Novartis AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Event Date | Event Description |
| Saturday, September 3, 2022 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |
| Saturday, September 3, 2022 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, October 4, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, September 13, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, September 13, 2019 | FINAL DISPOSITION PROCESSED |
| Wednesday, August 28, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, May 28, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 12, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 12, 2019 | PUBLISHED FOR OPPOSITION |
| Friday, March 8, 2019 | NOTIFICATION PROCESSED BY IB |
| Wednesday, February 20, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, February 20, 2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, February 20, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 5, 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, February 4, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, February 2, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, February 2, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, February 2, 2019 | ASSIGNED TO LIE |
| Friday, February 1, 2019 | REFUSAL PROCESSED BY IB |
| Tuesday, January 29, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 23, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, January 23, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Saturday, January 12, 2019 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, January 12, 2019 | REFUSAL PROCESSED BY MPU |
| Tuesday, January 1, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, December 31, 2018 | NON-FINAL ACTION WRITTEN |
| Monday, December 31, 2018 | ASSIGNED TO EXAMINER |
| Tuesday, December 18, 2018 | APPLICATION FILING RECEIPT MAILED |
| Friday, December 14, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, December 7, 2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, December 6, 2018 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |